[1] |
Guo Y, Li P, Tang J, et al. Prevalence of atopic dermatitis in Chinese children aged 1⁃7 ys[J]. Sci Rep, 2016,6:29751. doi: 10.1038/srep29751.
|
[2] |
张建中. 特应性皮炎的诊断标准发展及评价[J]. 中华皮肤科杂志, 2017,50(1):67⁃69. doi: 10.3760/cma.j.issn.0412⁃4030. 2017.01.025.
|
[3] |
中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南(2020版)[J]. 中华皮肤科杂志, 2020,53(2):81⁃88. doi: 10.35541/cjd.20191000.
|
[4] |
中国康复医学会皮肤病康复专业委员会. 中国特应性皮炎专病管理与诊疗现状白皮书[DB/OL]. (2022⁃09⁃17)[2025⁃3⁃31]. https://mp.weixin.qq.com/s/FMJxO6S_hEMsItfIUK7zWA?scene=25#wechat_redirect.
|
[5] |
王珊, 马琳. 特应性皮炎治疗挑战及解决对策[J]. 中华皮肤科杂志, 2018,51(1):69⁃71. doi: 10.3760/cma.j.issn.0412⁃4030. 2018.01.024.
|
[6] |
Biazus Soares G, Hashimoto T, Yosipovitch G. Atopic dermatitis itch: scratching for an explanation[J]. J Invest Dermatol, 2024,144(5):978⁃988. doi: 10.1016/j.jid.2023.10.048.
|
[7] |
中国医师协会皮肤科医师分会过敏性疾病专业委员会, 中华医学会皮肤性病学分会特应性皮炎研究中心, 中国医疗保健国际交流促进会皮肤科分会. 特应性皮炎瘙痒管理专家共识[J]. 中华皮肤科杂志, 2021,54(5):391⁃396. doi: 10.35541/cjd. 20210056.
|
[8] |
Udit S, Blake K, Chiu IM. Somatosensory and autonomic neuronal regulation of the immune response[J]. Nat Rev Neurosci, 2022,23(3):157⁃171. doi: 10.1038/s41583⁃021⁃00555⁃4.
|
[9] |
Kim BS, Artis D. The sensory neuroimmune frontier[J]. Immunity, 2025,58(5):1033⁃1039. doi: 10.1016/j.immuni.2025. 03.018.
|
[10] |
Igarashi A, Katsunuma T, Nagano Y, et al. Long⁃term (68 weeks) administration of nemolizumab in paediatric patients aged 6⁃12 years with atopic dermatitis with moderate⁃to⁃severe pruritus: efficacy and safety data from a phase Ⅲ study[J]. Br J Dermatol, 2025,192(5):837⁃844. doi: 10.1093/bjd/ljae458.
|
[11] |
Silverberg JI, Wollenberg A, Reich A, et al. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate⁃to⁃severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double⁃blind, randomised controlled phase 3 trials[J]. Lancet, 2024,404(10451):445⁃460. doi: 10.1016/S0140⁃6736(24)01203⁃0.
|
[12] |
Courtney A, Su JC. The psychology of atopic dermatitis[J]. J Clin Med, 2024,13(6):1602. doi: 10.3390/jcm13061602.
|
[13] |
Fasseeh AN, Elezbawy B, Korra N, et al. Burden of atopic dermatitis in adults and adolescents: a systematic literature review[J]. Dermatol Ther (Heidelb), 2022,12(12):2653⁃2668. doi: 10.1007/s13555⁃022⁃00819⁃6.
|
[14] |
Rønnstad A, Halling⁃Overgaard AS, Hamann CR, et al. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta⁃analysis[J]. J Am Acad Dermatol, 2018,79(3):448⁃456.e30. doi: 10.1016/j.jaad.2018.03.017.
|
[15] |
Ramirez FD, Chen S, Langan SM, et al. Association of atopic dermatitis with sleep quality in children[J]. JAMA Pediatr, 2019,173(5):e190025. doi: 10.1001/jamapediatrics.2019.0025.
|
[16] |
Fishbein AB, Cheng BT, Tilley CC, et al. Sleep disturbance in school⁃aged children with atopic dermatitis: prevalence and severity in a cross⁃sectional sample[J]. J Allergy Clin Immunol Pract, 2021,9(8):3120⁃3129. doi: 10.1016/j.jaip.2021.04.064.
|
[17] |
Kelly KA, Balogh EA, Kaplan SG, et al. Skin disease in children: effects on quality of life, stigmatization, bullying, and suicide risk in pediatric acne, atopic dermatitis, and psoriasis patients[J]. Children (Basel), 2021,8(11):1057. doi: 10.3390/children8111057.
|
[18] |
Paller AS, Rangel SM, Chamlin SL, et al. Stigmatization and mental health impact of chronic pediatric skin disorders[J]. JAMA Dermatol, 2024,160(6):621⁃630. doi: 10.1001/jamadermatol. 2024.0594.
|
[19] |
Cheng Y, Lu JW, Wang JH, et al. Associations of atopic dermatitis with attention deficit/hyperactivity disorder and autism spectrum disorder: a systematic review and meta⁃analysis[J]. Dermatology, 2024,240(1):13⁃25. doi: 10.1159/000533366.
|
[20] |
国家卫生健康委. 国家卫生健康委关于印发健康儿童行动提升计划(2021—2025年)的通知[J]. 中华人民共和国国家卫生健康委员会公报, 2021,19(10):28⁃32.
|
[21] |
Chamlin SL, Lai JS, Cella D, et al. Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness[J]. Arch Dermatol, 2007,143(6):768⁃772. doi: 10.1001/archderm.143.6.768.
|
[22] |
Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations[J]. Med Care, 2001,39(8):800⁃812. doi: 10.1097/00005650⁃200108000⁃00006.
|
[23] |
Radez J, Waite P, Chorpita B, et al. Using the 11⁃item version of the RCADS to identify anxiety and depressive disorders in adolescents[J]. Res Child Adolesc Psychopathol, 2021,49(9):1241⁃1257. doi: 10.1007/s10802⁃021⁃00817⁃w.
|
[24] |
国家食品药品监督管理总局药品审评中心. 儿科人群药物临床试验技术指导原则(征求意见稿)[J]. 中国临床药理学杂志, 2015,31(16):1696⁃1700. doi: 10.13699/j.cnki.1001⁃6821. 2015.16.041.
|
[25] |
Sun D, Ong PY. Infectious complications in atopic dermatitis[J]. Immunol Allergy Clin North Am, 2017,37(1):75⁃93. doi: 10.1016/j.iac.2016.08.015.
|
[26] |
Mansilla⁃Polo M, Morgado⁃Carrasco D. Biologics versus JAK inhibitors. PartⅡ: risk of infections. A narrative review[J]. Dermatol Ther (Heidelb), 2024,14(8):1983⁃2038. doi: 10.1007/s13555⁃024⁃01203⁃2.
|
[27] |
中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会. 中国中重度特应性皮炎诊疗临床路径专家共识(2023版)[J]. 中华皮肤科杂志, 2023,56(11):1000⁃1007. doi: 10. 35541/cjd.20230247.
|
[28] |
Park CO, Kim SM, Lee KH, et al. Biomarkers for phenotype⁃endotype relationship in atopic dermatitis: a critical review[J]. EBioMedicine, 2024,103:105121. doi: 10.1016/j.ebiom.2024. 105121.
|
[29] |
Guttman⁃Yassky E, Renert⁃Yuval Y, Brunner PM. Atopic dermatitis[J]. Lancet, 2025,405(10478):583⁃596. doi: 10.1016/S0140⁃6736(24)02519⁃4.
|
[30] |
Esaki H, Brunner PM, Renert⁃Yuval Y, et al. Early⁃onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin[J]. J Allergy Clin Immunol, 2016,138(6):1639⁃1651. doi: 10.1016/j.jaci.2016.07.013.
|
[31] |
Noda S, Suárez⁃Fariñas M, Ungar B, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization[J]. J Allergy Clin Immunol, 2015,136(5):1254⁃1264. doi: 10.1016/j.jaci.2015.08. 015.
|